ATE427993T1 - EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK - Google Patents

EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK

Info

Publication number
ATE427993T1
ATE427993T1 AT96946233T AT96946233T ATE427993T1 AT E427993 T1 ATE427993 T1 AT E427993T1 AT 96946233 T AT96946233 T AT 96946233T AT 96946233 T AT96946233 T AT 96946233T AT E427993 T1 ATE427993 T1 AT E427993T1
Authority
AT
Austria
Prior art keywords
long
syndrome
kvlqt1
gene
acid sequence
Prior art date
Application number
AT96946233T
Other languages
English (en)
Inventor
Mark Keating
Mark Curran
Gregory Landes
Timothy Connors
Timothy Burn
Qing Wang
Original Assignee
Univ Utah Res Found
Genzyme Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE427993(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Utah Res Found, Genzyme Genetics filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE427993T1 publication Critical patent/ATE427993T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT96946233T 1995-12-22 1996-12-20 EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK ATE427993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1901495P 1995-12-22 1995-12-22
US73938396A 1996-10-29 1996-10-29

Publications (1)

Publication Number Publication Date
ATE427993T1 true ATE427993T1 (de) 2009-04-15

Family

ID=26691739

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96945935T ATE352629T1 (de) 1995-12-22 1996-12-20 Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden
AT96946233T ATE427993T1 (de) 1995-12-22 1996-12-20 EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96945935T ATE352629T1 (de) 1995-12-22 1996-12-20 Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden

Country Status (11)

Country Link
EP (3) EP0876491B1 (de)
JP (2) JP2001519646A (de)
AT (2) ATE352629T1 (de)
AU (2) AU714041B2 (de)
CA (1) CA2240737C (de)
DE (2) DE69637895D1 (de)
DK (1) DK0876491T3 (de)
ES (1) ES2325820T3 (de)
NZ (2) NZ330744A (de)
PT (1) PT876491E (de)
WO (2) WO1997023632A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274332B1 (en) * 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US6277978B1 (en) * 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
JP4520634B2 (ja) 1997-10-24 2010-08-11 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 良性の家族性新生児痙攣(bfnc)および他の癲癇において突然変異されたkcnq2およびkcnq3−カリウムチャンネル遺伝子
GB9726339D0 (en) * 1997-12-13 1998-02-11 Zeneca Ltd Human-derived tissue-specific potassium channel
EP1056765A4 (de) * 1998-02-25 2003-07-30 Icagen Inc Menschliche kaliumkanal-gene
US6071720A (en) 1998-04-29 2000-06-06 Incyte Pharmaceuticals, Inc. Delayed rectifier potassium channel subunit
US6794161B1 (en) 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels
DK1147134T3 (da) * 1999-01-26 2007-02-05 Neurosearch As Hidtil ukendte kaliumkanaler og gener, der koder for disse kaliumkanaler
CA2380807A1 (en) 1999-08-09 2001-04-12 University Of Utah Research Foundation Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
AU7854900A (en) * 1999-10-08 2001-04-23 Vanderbilt University Method of screening for susceptibility to drug-induced cardiac arrhythmia
EP1176197A1 (de) * 2000-06-16 2002-01-30 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Transgenes Tiermodel für Herzarrythmien
US7034008B2 (en) * 2000-09-06 2006-04-25 The Johns Hopkins University Cardiac arrhythmia treatment methods
US8013133B2 (en) * 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US10917454B1 (en) 2019-08-01 2021-02-09 Rohde & Schwarz Gmbh & Co. Kg System and method for ATC voice quality assurance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
CA1188246A (en) 1981-08-31 1985-06-04 Jerry L. Gregory Immobilized microbe recycle apparatus
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5599673A (en) * 1995-03-09 1997-02-04 University Of Utah Research Foundation Long QT syndrome genes

Also Published As

Publication number Publication date
EP0870041B1 (de) 2007-01-24
NZ330744A (en) 1999-02-25
DE69636870T2 (de) 2007-11-08
DE69636870D1 (de) 2007-03-15
WO1997023632A1 (en) 1997-07-03
EP0876491B1 (de) 2009-04-08
CA2240737C (en) 2009-09-29
EP0870041A2 (de) 1998-10-14
DE69637895D1 (de) 2009-05-20
EP0876491A1 (de) 1998-11-11
PT876491E (pt) 2009-07-14
DK0876491T3 (da) 2009-07-06
WO1997023598A2 (en) 1997-07-03
JP2001519646A (ja) 2001-10-23
JP3449419B2 (ja) 2003-09-22
NZ330743A (en) 1999-07-29
EP0876491A4 (de) 2001-12-19
EP2085478A1 (de) 2009-08-05
ES2325820T3 (es) 2009-09-18
AU714041B2 (en) 1999-12-16
JP2001501445A (ja) 2001-02-06
WO1997023598A3 (en) 1997-09-12
AU1951297A (en) 1997-07-17
ATE352629T1 (de) 2007-02-15
CA2240737A1 (en) 1997-07-03
AU1742897A (en) 1997-07-17
EP0870041A4 (de) 2002-01-23
AU714527B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
ATE427993T1 (de) EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
Wagner et al. Reliability of three alternate forms of the trail making tests a and B
ATE522621T1 (de) Diagnose und behandlung von williams syndrom
WO2016138337A1 (en) Microbiome diagnostics
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
WO2003016494A3 (en) Diagnosis and treatment of vascular disease
ATE320006T1 (de) Methode zum nachweis von zell-apoptose
DE68928728D1 (de) Diagnose von retinoblastoma
WO2003020118A3 (en) Diagnosis and treatment of vascular disease
AU2020225197A8 (en) Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof
ATE534902T1 (de) Replikationsproteinn ciz1
Zeidler et al. Early arthritis and rheumatoid arthritis in Germany
DE69132361D1 (de) Der neurotrophen wimper faktor rezeptor
Bhagavati et al. The neurofilament light chain gene (NEFL) mutation Pro22Ser can be associated with mixed axonal and demyelinating neuropathy
EP0870036A4 (de) Synthetische säugetier alpha-n-aectylglukosaminidase und dafür kodierende genetische sequenzen
HUP0100674A2 (hu) Mutáns prepo-neuropeptid-Y-t kódoló DNS-molekula, mutáns szignálpeptid és alkalmazásuk
EP1471143A4 (de) Gegenüber einer rheumatoiden arthritis-erkrankung sensitives gen, sein protein, verfahren und kit zur beurteilung des ausbruchs von rheumatoider arthritis unter verwendung desselben sowie verfahren und arzneistoffe zur behandlung rheumatoider arthritis
WO2007008604A3 (en) Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof
Craine INTERNALITY AND NONCOGNITIVE PREDICTORS FOR SUCCESS OF ASSOCIATE DEGREE NURSING STUDENTS.
Barcat et al. Thrombophilia and thrombosis in systemic lupus erythematosus: a case-control study
Keating et al. Long QT syndrome genes
Roque et al. A NEW SCALE FOR ASSESSING OLDER ADULTS’WIRELESS NETWORK PROFICIENCY
Juul-Dam et al. Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0876491

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0876491

Country of ref document: EP